Multiple loci identified in a genome-wide association study of prostate cancer
By G. Thomas, K. Jacobs, M. Yeager, Peter Kraft, S. Wacholder, N. Orr, Kai Yu, N. Chatterjee, Robert W Welch, Amy K. Hutchinson and 29 more. Nature Genetics, 2008
973 citations recorded by the source corpus.
Subfields: Genetics, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/dceef8b0b2fd77997eb4a8d53e5ac7f5380784dd
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
- Gonçalo R. Abecasis
- Jonathan Marchini
- Cristen J. Willer
- Yun Li
- Mark J. Daly
- David Altshuler
- Michael Boehnke
- Peter Kraft
Citations in the corpus
- Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes (2008, background): “Very recently, a SNP in JAZF1 was identified as associated with prostate cance”
- Potential etiologic and functional implications of genome-wide association loci for human diseases and traits (2009, background): “* The well known association of JAZF1 with prostate cancer was reported with a p value of 2 � 10�6 (18), which did not meet the threshold of 5 � 10�8 for this analysis.”
- Genome-wide association study of circulating vitamin D levels (2010, methodology): “Quality-control assessment of genotypes, including sample completion and SNP call rates, concordance rates, deviation from fitness for the Hardy–Weinberg proportions in control DNA and final sample selection for association analyses, are described elsewhere (26–29).”
- Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21 (2011, neutral): “02 were not replicated in stage 2 CGEMS.(4) 0 0.”
- SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies (2009, background): “The CGEMS follow up study was particularly robust because it genotyped 26 958 SNPs, including all SNPs with P-value 5 ).”
- A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus (2009, background): “A separate prostate cancer risk allele near JAZF1 (rs10486567”
- Genetics and biology of prostate cancer (2018, background): “…(Lichtenstein et al. 2000); GWASs have identifiedmany prostate cancer susceptibility loci (Yeager et al. 2007; Eeles et al. 2008, 2009, 2013; Thomas et al. 2008;Gudmundsson et al. 2009; Yeager et al. 2009; Takata et al. 2010; Xu et al. 2012a; Schumacher et al. 2018), such as the…”
- Estimation of effect size distribution from genome-wide association studies and implications for future discoveries (2010, neutral): “We projected the total number of loci expected to be discovered in the Cancer Genetic Markers of Susceptibility (CGEMS) two-stage breast and prostate cancer studie”
- Molecular genetics of prostate cancer: new prospects for old challenges. (2010, background): “Additionally, genome-wide association studies have identified numerous single-nucleotide polymorphisms (SNPs) that are associated with cancer risk (Thomas et al. 2008; Eeles et al. 2009; Gudmundsson et al. 2009; Kader et al. 2009).”